Skip to main content
SpringerLink
Log in

Brief report: A double-blind study of naltrexone in infantile autism

  • Brief Reports
  • Published:
Journal of Autism and Developmental Disorders Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Anderson, L., Campbell, M., Grega, D., Perry, R., Small, A., & Green, W. (1984) Haloperidol in the treatment of infantile autism: effects on learning and behavioral symptoms.American Journal of Psychiatry, 141, 1195–1202.

    Google Scholar 

  • Bach, F. W. (1989). Beta-endorphin-related peptides in human cerebrospinal fluid. In A. R. Genazzani & M. Negri (Eds.),Opioid peptides in biological fluids (pp. 17–25). London, England: Parthenon.

    Google Scholar 

  • Barthelemy, C., Adrien, J. L., Boiron, M., Colombel, P., Langella, B., & Dansart, P. (1988). Les évaluations comportementales psychologiques et biologiques en psychiatrie de l'enfant. Problèmes méthodologiques-applications thérapeutiques.Psychologie Médicale, 18(5), 691–695.

    Google Scholar 

  • Barthelemy, C., Adrien, J. L., Tanguay, P., Garreau, B., Fermanian, J., Roux, S., Sauvage, D., & Lelord, G. (1990). The behavioral summarized evaluation: Validity and reliability of a scale for the assessment of autistic behaviors.Journal of Autism and Developmental Disorders, 20, 189–203.

    Google Scholar 

  • Campbell, M., & Palij, M. (1985). Behavioral and cognitive measures used in psychopharmacological studies of infantile autism.Psychopharmacology Bulletin, 21, 1047–1053.

    Google Scholar 

  • Campbell, M., Small, A., Palij, M., Perry, R., Polonosky, B., Lukashok, D., & Anderson, L. (1987). The efficacy and safety of fenfluramine in autistic children: Preliminary analysis of a double-blind study.Psychopharmacological Bulletin, 23, 123–127.

    Google Scholar 

  • Campbell, M., Adams, P., Perry, R., Spenser, E., Overall, J. (1988). Tardive dyskinesia in autistic children: A prospective study.Psychopharmacological Bulletin, 24, 251–256.

    Google Scholar 

  • Campbell, M., Adams, P., Small, A. M. et al. (1988). Naltrexone in infantile autism.Psychopharmacology Bulletin, 24, 135–139.

    Google Scholar 

  • Campbell, M., Overall, J., Small, A., Sokol, M., Spencer, E., Adams, P., Foltz, R., Monti, K., Nobler, M., Roberts, E. (1989). Naltrexone in autistic children: an acute open dose range trial.Journal of the American Academy of Child and Adolescent Psychiatry, 28, 200–206.

    Google Scholar 

  • Campbell, M., Anderson, L. T., Small, A. M., Locascio, J. J., Lynch, N. S., & Choroco, M. C. (1990). Naltrexone in autistic children: A double-blind and placebo-controlled study.Psychopharmacology Bulletin, 26, 130–135.

    Google Scholar 

  • Chamberlin, R. S., & Herman, B. H. (1990). A novel biochemical model linking dysfunctions in brain melatonin, proopiomelanocortin peptides and serotonin in autism.Biological Psychiatry, 28, 773–793.

    Google Scholar 

  • Deutsch, S. (1986). Rationale for the administration of opiate antagonists in treating infantile autism.American Journal of Mental Deficiency, 90, 631–635.

    Google Scholar 

  • Gillberg, C.,(1988). The role of the endogenous opioids in autism and possible relationships to clinical features. In L. Wing (Ed.),Aspects of autism: Biological research, Oxford, U.K.: Alden (pp. 31–37).

    Google Scholar 

  • Gillberg, C., Terenius, L., Lonnerholm, G. (1985). Endorphin activity in childhood psychosis: Spinal fluid levels in 24 cases.Archives of General Psychiatry, 42, 780–783.

    Google Scholar 

  • Herman, B. (1991). Effects of opioid receptor antagonists in the treatment of autism and self-injurious behavior. In J. J. Ratey (Ed.),Mental retardation: Developing Pharmacotherapies. Progress in psychiatry #32 (pp. 107–137). Washington, D.C.: American Psychiatric Press.

    Google Scholar 

  • Herman, B., Hammock, K., Arthur-Smith, A., Kuehl, K., & Appelgate, K. (1989). Effects of acute administration of Naltrexone on cardiovascular function, body temperature, body weight and serum concentrations of liver enzymes in autistic children.Developmental Pharmacological Therapeutics, 12, 118–127.

    Google Scholar 

  • Herman, B., Hammock, K., Arthur-Smith, A., Egan, J., Chatoor, I., Werner, A., & Zelnik, N. (1987). Naltrexone decreases self-injurious behavior.Annals of Neurology, 22, 550–552.

    Google Scholar 

  • Kerdelhue, B., Bethea, C. L., Ling, N., Chrétien, M., & Weiner, R. I. (1982). b-Endorphin concentrations in serum, hypothalamus and central grey of hypophysectomized and medio-basal hypothalamus lesion rats.Brain Reserach, 231, 85–91.

    Google Scholar 

  • Kerdelhue, B., Kartezi, M., Pasqualini, C., Rainberg, A., Mezay, E., & Palkovits, M. (1983). Circadian variations in beta-endorphin concentrations in pituitary and in some brain nuclei of adult male rat.Brain Research, 261, 243–248.

    Google Scholar 

  • Lake, R., Ziegler, M., & Murphy, D. (1977). Increased norepinephrine levels and decreased dopamine-b-hydroxylase activity in primary autism.Archives of General Psychiatry, 34, 553–556.

    Google Scholar 

  • Launay, J. M., Bursztejn, C., Ferrari, P., Dreux, C., Braconnier, A., Zarifian, E., Lancrenon, S., & Fermanian, J. (1987). Catecholamines metabolism in infantile autism. A controlled study of 22 autistic children.Journal of Autism and Developmental Disorders, 17, 333–347.

    Google Scholar 

  • Leboyer, M., Bouvard, M., & Dugas M. (1988). Effects of naltrexone on infantile autism.Lancet, 1 8587–8715.

    Google Scholar 

  • Lensing, P., Klingler, D., Gerstl, W., & Panksepp, J. (1989).Clinical notes on naltrexone therapy for five autistic children: Provisional guidelines for future research. Collected Papers of the Autism Research Unit Meeting on the “Experimental Biology and the Autistic Syndromes” at The College of St Hild and St Bede, Univ. of Durham, March 29–31, 1989. (Copies can be obtained from Autism Research Unit, School of Pharmaceutical and Chemical Sciences, Sunderland Polytechnic, Ryhope Road, Sunderland SR 2 7EE, UK or the National Autistic Society, 276 Willesden Land, London NW2 5RB, U.K.

  • Panksepp, J. (1979). A neurochemical theory of autism.Trends in Neuroscience, 2, 174–177.

    Google Scholar 

  • Panksepp, J. (1981). Brain opioids: A neurochemical substrate for narcotic and social dependence. In S. Cooper (Ed.),Progress in theory in psychopharmacology, (pp. 149–175). London: Academic Press.

    Google Scholar 

  • Panksepp, J. & Lensing, P. (1990). Naltrexone therapy of autistic children. In: J. M. Van Ree, A. H. Mulder, W. M. Wiegant, & T. B. Van Wimersma Greidanus (Eds.),New ideas in opioid research (pp. 181–182). Amsterdam: Exerptal Medica.

    Google Scholar 

  • Panksepp, J. & Lensing, P. (1991). Naltrexone treatment of autism: A synopsis of an opentrial with four children.Journal of Autism and Developmental Disorders, 21, 135–141.

    Google Scholar 

  • Panksepp, J. & Sahley, T. (1987). Possible brain opioid involvement in disrupted social intent and language development of autism. In E. Schopler & G. Mesibov (Eds.)Neurobiological issues in autism (pp. 357–373). New York: Plenum Press.

    Google Scholar 

  • Rimland, B. (1991). Vitamin B6 vs. fenfluramine: A case study in medical bias.Autism Research Review International, 5(1), 3.

    Google Scholar 

  • Sahley, T. L. & Panksepp, J. (1987). Brain opioids and autism: an updated analysis of possible linkages.Journal of Autism and Developmental Disorders, 17, 201–216.

    Google Scholar 

  • Sandyk, R., & Gillman, M. A. (1986). Infantile autism: A dysfunction of the opioids?Medical Hypotheses, 29, 41–45.

    Google Scholar 

  • Vittet, D., Launay, J. M., & Chevillard, C. (1989). Short-term homologous regulation of human platelet vasopressin receptor does not occur in vivo.American Journal of Physiology, 257, 1400–1405.

    Google Scholar 

  • Walters, A. S., Barrett, R. P., Feinstein, C., Mercurio, A., & Hole, W. T. (1990). A case report of naltrexone treatment of self-injury and social withdrawal in autism.Journal of Autism and Developmental Disorders, 20, 169–176.

    Google Scholar 

  • Weizman, R., Weizman, A., Tyano, S., Szekely, G., Weissman, B., & Sarne, Y. (1984). Humoral-b-endorphin blood levels in autistic, schizophrenic and healthy subjectsPsychopharmacology, 82, 368–370.

    Google Scholar 

  • Weizman, R., Gil-Ad, I., Dick, J., et al. (1988). Low plasma immunoreaction B-endorphin levels in autistics.Journal of the American Academy of Child and Adolescent Psychiatry, 27, 430–433.

    Google Scholar 

  • Young, J., Kavanagh, M., Anderson, G., Shaywitz, B., & Cohen, D. (1982). Clinical neurochemistry of autism and associated disorders.Journal of Autism and Developmental Disorders, 12, 147–165.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Unité de Recherche en Génétique Épidémologique, INSERM U 155, Paris

    Marion Leboyer

  2. Service de Psychopathologie de l'Enfant et de l'Adolescent, HôpitalRobert Debré, Paris

    Manuel P. Bouvard & Délphine Waller

  3. Fra. C. Bernard. “Neurochimie des Communications Cellulaires”, Hôpital St-Louis, Paris

    Jean-Marie Launay & François Tabuteau

  4. Laboratoire de Neurobiologie de la Reproduction, C.N.R.S., INRA, Jouy en Josas

    Bernard Kerdelhue

  5. School Psychology of Upper Austria, Linz

    Patrick Lensing

  6. Department of Psychology, Bowling Green State University, 43403, Bowling Green, Ohio

    Jaak Panksepp

Authors
  1. Marion Leboyer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Manuel P. Bouvard
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jean-Marie Launay
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. François Tabuteau
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Délphine Waller
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Michel Dugas
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Bernard Kerdelhue
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Patrick Lensing
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Jaak Panksepp
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

This work was supported by INSERM. We are grateful to Du Pont, de Nemours who provided us with the drug. The authors thank N. Cauet for her expert technical assistance.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Leboyer, M., Bouvard, M.P., Launay, JM. et al. Brief report: A double-blind study of naltrexone in infantile autism. J Autism Dev Disord 22, 309–319 (1992). https://doi.org/10.1007/BF01058158

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01058158

Keywords

Search

Navigation